Hello Friends / members,despite the market trying to blur the...

Hello Friends / members,
despite the market trying to blur the potential and projects in the course of work of Neuren, my research and convictions that in the near future we will have to deal with Roche, find more and more feedback.whether they are "conspiracies" or realistic elements we will find out later, but in fact the movements in parallel between the initiatives of Roche, Neuren and the market coincide dramatically.I leave you to the reflection of the followingn May 16th Roche officially turns to Angelman Syndrome comunity with this release:

https://www.angelman.org/roche-biogen-and-ionis-announce-collaborative-research-partnership/

On May 17th Neuren announces positive effects in Angelman syndrome:

https://stocknessmonster.com/announcements/neu.asx-2A1149883/

the market at that precise moment has embarked on a positive path that has resulted in a doubling of the starting price.I won't add anything else, for now ...